Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines—Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum—Given Concomitantly with Influenza Vaccine to High-Risk Elderly Individuals

Ann R. Falsey1 Edward E. Walsh1 Jose Capellan14 Stefan Gravenstein23 Maria Zambon12 Eddy Yau14 Geoffrey J. Gorse5 Robert Edelman6 Frederick G. Hayden4 Janet E. McElhaney7 Kathleen M. Neuzil8 Kristen L. Nichol9 Eric A. F. Simões10 Peter F. Wright11 and Valérie M.-P. Sales13

首页> 外文期刊>Journal of Infectious Diseases >Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines—Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum—Given Concomitantly with Influenza Vaccine to High-Risk Elderly Individuals

【24h】

Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines—Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum—Given Concomitantly with Influenza Vaccine to High-Risk Elderly Individuals

机译：两种呼吸道合胞病毒（RSV）疫苗的安全性和免疫原性比较—高危老人同时给予不带佐剂的疫苗或加明矾的佐剂—同时给予流感疫苗

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background. Respiratory syncytial virus (RSV) has been recognized recently as an important adult pathogen.

机译：背景。呼吸道合胞病毒（RSV）最近被公认为是重要的成人病原体。

著录项

来源
《Journal of Infectious Diseases》 |2008年第9期|p.1317-1326|共10页
作者
Ann R. Falsey1 Edward E. Walsh1 Jose Capellan14 Stefan Gravenstein23 Maria Zambon12 Eddy Yau14 Geoffrey J. Gorse5 Robert Edelman6 Frederick G. Hayden4 Janet E. McElhaney7 Kathleen M. Neuzil8 Kristen L. Nichol9 Eric A. F. Simões10 Peter F. Wright11 and Valérie M.-P. Sales13;
展开▼
作者单位

1 Department of Medicine, Rochester General Hospital, and University of Rochester School of Medicine, Rochester, New York 2 Department of Medicine, Brown University School of Medicine, Providence, Rhode Island 3 Eastern Virginia Medical School, Norfolk 4 Divisions of Infectious Diseases and International Health, University of Virginia, School of Medicine, Charlottesville, Virginia 5 St. Louis Department of Veterans Affairs Medical Center and Saint Louis University, St. Louis, Missouri 6 Department of Medicine and Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 7 Center for Immunotherapy of Cancer and Infectious Diseases, University of Connecticut School of Medicine, Farmington, Connecticut 8 PATH and University of Washington School of Medicine, Seattl;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals. [J] . Falsey AR, Walsh EE, Capellan J, The Journal of Infectious Diseases . 2008,第9期

机译：两种呼吸道合胞病毒（rsv）疫苗（非佐剂疫苗或明矾佐剂疫苗）与流感疫苗同时提供给高危老年人的安全性和免疫原性比较。
2. Immunogenicity and Safety of the Influenza A/H1N1 2009 Inactivated Split-Virus Vaccine in Young and Older Adults: MF59-Adjuvanted Vaccine versus Nonadjuvanted Vaccine [J] . Hee Jin Cheong, Joon Young Song, Jung Yeon Heo, Clinical and vaccine immunology: CVI . 2011,第8期

机译：年轻人和老年人中2009年A / H1N1流感灭活的分裂病毒疫苗的免疫原性和安全性：MF59辅助疫苗与非辅助疫苗
3. Safety of MF59-adjuvanted influenza vaccination in the elderly: Results of a comparative study of mf59-adjuvanted vaccine versus nonadjuvanted influenza vaccine in Northern Italy [J] . VillaM., BlackS., GrothN., American Journal of Epidemiology . 2013,第7期

机译：MF59辅助流感疫苗在老年人中的安全性：意大利北部mf59辅助疫苗与非辅助流感疫苗的比较研究结果
4. Improved immunogenicity and plaque reduction from single dose combination respiratory syncytial virus (RSV) vaccine microparticle formulations [C] . K.Sokoll, P.Frank, S.Craig, International symposium on controlled release of bioactive materials;Consumer and diversified products conference . 2000

机译：单剂量联合呼吸道合胞病毒（RSV）疫苗微粒制剂可改善免疫原性并减少斑块
5. A rhesus monkey model of respiratory syncytial virus (RSV) to evaluate the immunogenicity and protective efficacy of a DNA vaccine. [D] . Vaughan, Kerrie Colleen McArthur. 2002

机译：呼吸道合胞病毒（RSV）的恒河猴模型，用于评估DNA疫苗的免疫原性和保护功效。
6. Immunogenicity and Safety of the Influenza A/H1N1 2009 Inactivated Split-Virus Vaccine in Young and Older Adults: MF59-Adjuvanted Vaccine versus Nonadjuvanted Vaccine [O] . Hee Jin Cheong, Joon Young Song, Jung Yeon Heo, 2011

机译：年轻人和老年人中2009年A / H1N1流感灭活的分裂病毒疫苗的免疫原性和安全性：MF59辅助疫苗与非辅助疫苗
7. Immunogenicity and Safety of the Influenza A/H1N1 2009 Inactivated Split-Virus Vaccine in Young and Older Adults: MF59-Adjuvanted Vaccine versus Nonadjuvanted Vaccine▿† [O] . Cheong, Hee Jin, Song, Joon Young, Heo, Jung Yeon, 2011

机译：年轻人和老年人中2009年A / H1N1流感灭活的分裂病毒疫苗的免疫原性和安全性：MF59辅助疫苗与非辅助疫苗▿†

Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines—Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum—Given Concomitantly with Influenza Vaccine to High-Risk Elderly Individuals

摘要

著录项

相似文献

相关主题

期刊订阅